| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $35.17B | +10.7% |
| Cost of Revenue | $12.89B | +13.1% |
| Gross Profit | $22.28B | +9.4% |
| R&D Expense | $709.0M | +10.4% |
| Operating Income | $11.56B | -5.6% |
| Interest Expense | $1.53B | +98.7% |
| Pre-tax Income | $10.45B | -10.2% |
| Income Tax | $2.34B | +4.2% |
| Net Income | $7.81B |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.06B | -4.6% |
| Accounts Receivable | $3.46B | -10.1% |
| Inventory | $10.77B | +9.0% |
| Current Assets | $19.75B | +0.7% |
| Total Assets | $65.30B | +5.9% |
| Current Liabilities | $26.38B | -3.5% |
| Long-term Debt | $41.24B | +18.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $9.20B | -14.8% |
| Capital Expenditures | $1.32B | +22.7% |
| Investing Cash Flow | -$3.60B | +77.1% |
| Financing Cash Flow | -$5.58B | -246.7% |
| Free Cash Flow | $7.88B | -18.9% |
| -13.6% |
| EPS (Basic) | $5.02 | -13.7% |
| EPS (Diluted) | $5.02 | -13.6% |
| Total Liabilities |
| $74.75B |
| +9.9% |
| Stockholders' Equity | -$11.22B | -25.3% |